RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+26.7%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+26.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 73.83% |
| 2023 | -21.94% |
| 2022 | 54.91% |
| 2021 | 36.34% |
| 2020 | -149.93% |
| 2019 | -18.63% |
| 2018 | 24.87% |
| 2017 | -61.92% |
| 2016 | -45.83% |
| 2015 | -45.94% |